The International Cannabis Organization Conference would like to encourage international cannabis entrepreneurs and cannabis enthusiasts to verify out the upcoming International Healthcare Cannabis Conference (CannX). Beneath is additional information and facts about the occasion:
The international healthcare cannabis conference focusing on organization, technologies and agriculture will take spot for the fourth year in a row on September 9-10.
The conference will involve a politics session focusing on the problem of healthcare cannabis and the upcoming election campaign.
Conference speakers will involve:
- CannX Chairman Prof. Raphael Mechoulam, THC Cannabinoid Trailblazer and Israel Prize Recipient
- Kevin Roland, Director, Canopy Development Corporation, Canada
- Philippe Lucas, VP, International Patient Investigation & Access, Tilray, Canada
- Jonathan Web page, Chief Science Officer, Aurora Cannabis Inc., Canada
- Steve Hawkins, President and CEO of Horizons ETFs,Canada
- Ziva Eger, Chief Executive of Foreign Investments & Industrial Co-operation, Israel
- Minister of Agriculture Uri Ariel
- Prof. Arnon Afek, Acting Chief Doctor, Israeli Healthcare Cannabis Agency, Ministry of Overall health and former Director Common of the Ministry of Overall health
- Itai Malchior, Head of the Inter-Ministerial Committee for the Export of Medicinal Cannabis, Foreign Trade Administration, Ministry of Economy & Sector
The 4th International Healthcare Cannabis Conference (CannX) will take spot on 9-10 September at the Expo Tel Aviv venue. The CannX practical experience has been refined to present some of the most powerful networking in the organization and access to important opinion leaders. An estimated 1,00 senior choice makers from the complete international cannabis market worth chain are anticipated to participate in the international conference. Amongst them entrepreneurs, investors, growers, physicians, researchers, senior choice makers in healthcare cannabis firms, pharmacists and individuals.
The conference will take spot for the 4th consecutive year in partnership with Cann10, which manufactures and markets healthcare cannabis merchandise and technologies and Kenes, a skilled conference organizer.
CannX is the only healthcare cannabis conference which is accredited as a scientific conference by the European Accreditation Council for Continuing Healthcare Education (EACCME). This year, attendees at CannX will delight in a additional dynamic and interactive plan – permitting them to participate straight in debates and discussions.
Inside the principal conference subjects:
September 9 (Monday):
10:00 OPENING SESSION’ Uri Ariel, Minister of Agriculture
10:15 OPENING SESSION, Yossi Bornstein, Founder, Companion and Owner, Cann10, Founder, Shizim Group, Biomed holding group.
10:30 KEYNOTE LECTURE: THE CANNABINOID Method: Exactly where DO WE STAND Currently? Prof. Raphael Mechoulam, CannX Chairman, THC Cannabinoid Trailblazer and Israel Prize Recipient
11:30 SESSION: CANNABIS AND THE OPIOD EPIDEMIC, Chair: Elyad Davidson, Director, Discomfort Relief Unit at Hadassah Hebrew University Healthcare Center, Israel David Casarett, Prof. Chief of Palliative Care, Duke University, USA Philippe Lucas, VP of Patient Investigation and Access, Tilray, Canada
12:20 SESSION: THE ISRAEL MODEL: A Modest Nation, A Major Sector, Chair: Kobi Caspi, Co-founder and CFO, Cann10, Israel, Karina Rubinstein, Director of Organization Improvement, Commence Up Division at Israel Innovation Authority, Israel Ziva Eger, Chief Executive of Foreign Investments & Industrial Cooperation Amir Goldstein, Chief Operations
Officer, IMC, Israel Tal Ben David, Head Pharmacist, GreenPharma, Israel Liron Goldshtein, Head, Cannabis Pharmacy Dept., GreenPharma, Israel
12:20 SESSION: CANNABIS GENETICS – NEW DEVELOPMENTS, Chair: Shay Avraham Sarid, Co-Founder & CTO, Seach Healthcare Cannabis Group, Israel Jonathan Web page, Chief Scientist, Aurora Cannabis Inc., Canada Arnon Heyman, CEO, Canonic Ltd., Israel
14:30 SESSION: THE Effect OF CANNABIS-Primarily based Remedy ON Several Ailments – PRE-CLINICAL AND CLINICAL Outcomes, Chair: Reuven Or, Prof MD Cancer Immunotherapy & Immunobiology Investigation Center, Hadassah University Hospital, Israel Yossi Tam (ENDOCANNABINOID Method IN HUMAN PHYSIOLOGY) Gurmit Singh (CBDA-ME AND PERIPHERAL NEUROPATHIC Discomfort) Ruth Djaldetti (CANNABIS AND PARKINSON) Vered Hermush (DEMENTIA AND CANNABIS) Avi Priel (Discomfort AND IONOTROPIC CANNABINOIDS RECEPTORS) Reuven Or and Osnat Almogi-Hazan (CANNABIS IN
14:30 SESSION: DIGITAL Overall health AND CANNABIS – IS THE FUTURE Right here? Major Information, PREDICTION, AND ARTIFICIAL INTELLIGENCE, Chair: Gali Weinreb, Editor and Biomed correspondent, Globes, Israel Itzhak Kurek, CEO and Co-Founder, Cannformatics Inc., USA David Berg, President and CTO, Strainprint Technologies Ltd., Canada Avihu Tamir, CEO, Kanabo Investigation, Israel
September 10 (Tuesday):
10:00 SESSION: Getting into THE PHARMACEUTICAL Sector – HOW TO MEET PHARMA Requirements IN CANNABIS Primarily based Solutions, Arnon Afek, Associate Director Common, Sheba Healthcare Center, Acting Chief Doctor, Israeli Healthcare Cannabis Agency, Ministry of Overall health, Israel Kevin Roland, Director, CMC (Chemical Manufacturing Controls), Canopy Overall health Innovation, Canopy Development Corporation, Canada Patrick Schmitt, Molecular biologist, Co-Founder and Chief Science Officer, Farmako, Germany Ianiv Eisenscher, Chief Item Officer, Syqe Healthcare, Israel Orna Dreazen, CEO and Chairperson of the Board of Directors, Nextar Chempharma Options Ltd., Israel
12:00 Selection-MAKERS PANEL – THE POLITICAL ANGLE OF THE Healthcare CANNABIS FIELD Moderator: Dafna Liel, Channel 12 Knesset Correspondent, Politician panelists participating will be disclosed later on.
14:00 SESSION: International TRADE: OVERCOMING IMPORT-EXPORT BARRIERS IN A Consistently Altering REGULATORY Atmosphere, Moderator: Lior Kenan, Chanel 13 Economics Correspondent, Israel Itai Melchior, Senior Project Manager at Foreign Trade Administration – Ministry of Economy and Sector, Israel Elizabeth Hatchuel, Adjunct Professor, Universidade Federal Rural do Rio de Janeiro, Brazil
16:00 SESSION: THE Healthcare CANNABIS CAPITAL Market place – AN Financial BUBBLE OR THE True Factor? Moderator: Sophie Shulman, Capital Markets Editor, Calcalist, Israel, Steve Hawkins, President and CEO, Horizons ETFs, Canada Shiry Eden, Founder and CEO, Nishot, Israel Brenda Smith, CEO & Founder, CB Capital Concierge, Inc., USA Ilan Gerzi, Adv., Senior Companion and Head of the Capital Markets Division, Pearl Cohen, Israel
Ori Alperovitz, Cann10 CEO: “In the previous decade, healthcare cannabis has gone by way of a dramatic image shift, from a risky drug to a genuine plant with special healthcare qualities which have but to be totally exposed. Each and every year, the CannX conference draws hundreds of senior choice makers from the complete international cannabis market worth chain, who are thirsty for sources of information and new investment channels inside this field, to Israel.
A young and continually evolving field, the international cannabis market is going by way of frequent modifications due to altering regulatory policies and scientific breakthroughs made by the healthcare neighborhood. Our Cann10 accelerator is normally on the lookout for sensible, customized cannabis technologies spearheading the revolutionary cannabis arena worldwide.
Cann10 is an international business for improvement and promoting of healthcare cannabis merchandise and revolutionary technological entrepreneurship inside this field. Cann10 owns and distributes the “Cannareet” brand sold in Israeli pharmacies inside the new healthcare cannabis regulations (30% industry share). Amongst business activities in Israel and abroad: improvement and promotion of healthcare cannabis startups inside the CannXL accelerator management of a healthcare cannabis entrepreneurship course in collaboration with the Technion (Israel Institute of Technologies) entrepreneurship and management of scientific, technological and organization conferences inside the healthcare cannabis field in Israel and other components of the globe partnership in factory and breeding farm establishment in a quantity of nations.